UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 78690 / August 26, 2016
Admin. Proc. File No. 3-17256
In the Matter of
JINZANGHUANG TIBET
PHARMACEUTICALS, INC.

NOTICE THAT INITIAL DECISION HAS BECOME FINAL
The time for filing a petition for review of the initial decision in this proceeding has
expired. No such petition has been filed by JinZangHuang Tibet Pharmaceuticals, Inc., and the
Commission has not chosen to review the decision on its own initiative.
Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
of Practice,1 that the initial decision of the administrative law judge has become the final
decision of the Commission with respect to JinZangHuang Tibet Pharmaceuticals, Inc.2 The
order contained in that decision is hereby declared effective. The initial decision ordered that,
pursuant to Section 12(j) of the Securities Exchange Act of 1934, the registration of each class of
registered securities of JinZangHuang Tibet Pharmaceuticals, Inc., is revoked.
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.

Brent J. Fields
Secretary
1
2

17 C.F.R. ยง 201.360(d).

Dragon Bright Mintai Botanical Tech. Cayman Ltd., JinZangHuang Tibet Pharm., Inc., and
Macau Res. Grp. Ltd., Initial Decision Release No. 1034 (July 11, 2016), 114 SEC Docket 11,
2016 WL 4035561. The stock symbol and Central Index Key number is JZHG and 910832 for
JinZangHuang Tibet Pharmaceuticals, Inc.

